Novo Nordisk | NVO - Pre Tax Profit

Stock Price
37.61
Daily Change
0.70 1.90%
Monthly
-5.43%
Yearly
-42.25%
Q2 Forecast
35.05

Novo Nordisk reported DKK25.52B in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
ANI Pharmaceuticals USD 49.52M 39M Sep/2025
Aurora Cannabis CAD -1.58M 48.55M Dec/2025
Bausch Health Companies USD 218M 78M Sep/2025
Bristol-Myers Squibb USD 3.11B 1.34B Sep/2025
Canopy Growth CAD -62.26M 60.84M Dec/2025
Corcept Therapeutics USD 15.24M 16.45M Sep/2025
Drreddys Laboratories INR 15.43B 1.96B Dec/2025
Eli Lilly USD 7.23B 456M Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
Merck USD 6.74B 22M Sep/2025
Nektar Therapeutics USD -34.7M 2.35M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Novo Nordisk DKK 33.8B 3.23B Jun/2025
Novo Nordisk DKK 25.52B 8.29B Sep/2025
Pacira USD 9.52M 11.45M Sep/2025
Perrigo USD 22.4M 19.2M Sep/2025
Phibro Animal Health USD 38.62M 1.26M Dec/2025
Prestige Brands USD 69.13M 7.35M Sep/2025
Sanofi EUR -1.16B 5.5B Dec/2025
Supernus Pharmaceuticals USD -1.91M 56.04M Dec/2025
Zoetis USD 887M 15M Sep/2025